Stroke
September 2016 involvement on brain biopsy (n=26), digital subtraction angiography (n=49), and magnetic resonance angiography (n=10). We excluded patients with a presentation compatible with vasculopathy (unless they had a positive biopsy), such as atherosclerosis or reversible cerebral vasoconstriction syndrome. The cohort now includes 85 patients (a report on the first 52 patients was published in 2014). 2 For the present study, we specifically looked at those patients with tumor-like presentation of PACNS at diagnosis. They all had (1) an isolated neurological disorder and (2) brain magnetic resonance imaging (MRI) work-up at diagnosis, demonstrating unique or multiple contrastenhanced mass(es) or infiltrative lesion(s), with perilesional edema and mass effect, not linked to ischemic lesions on diffusion-weighted imaging, and (3) demonstration of vascular involvement on biopsy or digital subtraction angiography.
Studied Variables and Definitions
Using a standardized form, characteristics of each patient were retrieved from their medical records, as described earlier. 2 Neuroimaging studies were centrally reviewed by 2 neuroradiologists (G. Boulouis and O. Naggara) unaware of clinical manifestations. Results of MRI were collected. As performed previously, we differentiated large-, medium-, and small-sized vessels. 6, 7 Intracranial internal carotid and proximal anterior (A1), middle (M1), and posterior (P1) cerebral arteries were considered large; second divisions (A2, M2, and P2) and subsequent branches (>A2, >M2, and >P2) were considered medium-and small-sized, respectively. When available, magnetic resonance spectroscopy results were collected, as well as those of repeated MRI at the end of treatment.
Statistical Analyses
Categorical variables are expressed as number (%) and quantitative variables as median (range). Categorical variables were analyzed with the Chi-square or Fisher exact test, as appropriate, and quantitative variables with Wilcoxon's rank-sum test. Statistical analyses were computed with GraphPad Prism (5.0c). A P value ≤0.05 defined statistical significance.
Results
Characteristics of the 10 patients with tumor-like presentation identified in the cohort are shown in Table (Table I in the online-only Data Supplement). All had a biopsy (stereotactic procedure in 7 and open-wedge surgery in 3), and histological findings suggestive of vasculitis were observed in 9, including 8 (89%) with a lymphocytic pattern. The patient with a negative biopsy (histological samples contained little brain tissue) had diffuse bilateral large-and medium-sized vessel involvement on magnetic resonance angiography and digital subtraction angiography and exhaustive negative investigations that ruled out other conditions. In 4 patients, immunohistochemistry studies on biopsy samples combined with gene rearrangement studies excluded lymphoproliferative disease.
Seven patients showed masses on MRI (single and multiple lesions in 4 and 3 cases, respectively), with edema and mass effect in 3 and 5 cases, respectively (Figure) . In 3 other patients, MRI showed white matter infiltrative lesions with edema and mass effect. Three patients underwent magnetic resonance spectroscopy, the results of which were not suggestive of malignant process.
When compared with patients from the cohort without tumor-like presentation, the 10 patients were younger (median, 37 [30-48] years versus 46 years; P=0.008) and more presented with seizures at diagnosis (9/10 (90%) versus 22/75 (29%); P<0.001). Except for the patient with a noncontributory biopsy, the other 9 patients had negative digital subtraction angiography and magnetic resonance angiography, suggestive of isolated small-sized vessel PACNS.
Nine of the 10 patients with tumor-like presentation received glucocorticoid combined with cyclophosphamide (6 pulses, given over a median of 5 [3-6] months). With a 
Discussion
Tumor-like presentation is a rare feature of PACNS and has not been thoroughly characterized 8, 9 (Table II in the onlineonly Data Supplement). According to the previous literature, the present series shows that most patients with tumor-like PACNS have a negative vascular imaging, which suggests a preponderant small-vessel involvement. In this setting, biopsy remains crucial for diagnosis. Immunostainings and combined gene rearrangement studies, as performed in 4 patients of the present series, are useful for differentiating PACNS from lymphoma. In the study from Molloy et al, a granulomatous pattern was observed on histological study in 53% of the cases and lymphocytic pattern in the others. 9 In the present series, however, the lymphocytic vasculitis pattern was the rule.
Although the 10 patients were younger than others from our PACNS cohort and had more seizure and gadolinium enhancements, we did not identify clinical or radiological signs specific enough to suggest a PACNS in a patient with tumor-like presentation. Outcomes were favorable in our patients using the combination of glucocorticoids and cyclophosphamide, although relapses were not uncommon. In relapsing or refractory patients, rituximab could probably represent an alternative option. 10 The retrospective design and the small sample size are 2 limitations of our study and may have precluded the identification of small differences between patient subgroups. Nevertheless, because the 10 patients were extracted from one of the largest cohort PACNS ever reported, we assume that our findings offer new insights on the peculiar subgroup of patients with PACNS and tumor-like presentation. In addition, patient population was self-selected or referred to 25 tertiary centers, raising the possibility of referral bias and artificially increasing incidence of tumor-like PACNS. Finally, functional imaging, such as magnetic resonance spectroscopy, was not routinely performed in our cohort, precluding the identification of differences before biopsy between malignant neoplasm and tumor-like PACNS.
In conclusion, our study highlights the characteristics of patients with tumor-like presentation of PACNS. Although these patients showed nonspecific clinico-radiological differences from those without such tumor-like lesions, diagnostic and therapeutic approaches are similar. Biopsy is mandatory to demonstrate vasculitis and rule out other conditions, especially malignancy. Treatment, although not validated by prospective trials, should include a combination of glucocorticoids and immunosuppressant. The medical literature on the tumoral presentation of PACNS was reviewed from January 1990 to February 2016, inclusively, using PubMed (including MEDLINE and Pre-MEDLINE databases), limiting searches to adults. We used the following keywords: "primary angiitis of the central nervous system" or "primary cerebral vasculitis" or "primary central nervous system vasculitis", which were each linked to "tumor-like", "mass", "tumor", "tumoral" or "pseudotumoral". All relevant articles were retrieved and any additional references quoted in these articles were checked.
Sources of Funding
We only retained articles reporting patients with 1) definite diagnosis of PACNS obtained with diagnosis criteria according to Mallek and Calabrese;
1 2) tumoral presentation defined as single or multiple space-occupying parenchymal lesion(s); 3) available MRI described in the publication; 4) peer-reviewed publication; 5) individual patient data and 6) in English or French.
In some studies, only subsets of patients met the inclusion criteria and only these were included. We used a data-extraction form subdivided into 4 sections: 1) baseline characteristics, 2) biological and histological exploration, 3) imaging data and 4) outcomes.
Supplemental Results

Data from the literature
We identified 37 articles, mostly single case reports or short series of a few patients and excluded 18 of them because of lack of individual detailed information, including the study with literature review from Molloy et al. 2 References given within these articles were checked and included in our analysis if individual data was available.
Detailed data was available in the 19 selected articles for a total of 22 patients (male/female: 11/11; median age 42 years), whose main characteristics are described in Supplemental Table II . [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] Focal deficit was the most frequent presenting symptom in 12 (54%) patients, followed by headaches in 11 (50%). Imaging revealed a single mass in 13 (62%) patients, supratentorial in 11 4, 6-10, 13, 17, 19, 20 and involving the spinal cord in two. 4, 5 In seven other patients, MRI demonstrated multiple supratentorial well-delimited masses including infratentorial and spinal cord involvement in one. 12-15, 18, 21 In two other patients, MRI showed white matter infiltrative lesions. 11, 16 Vascular imaging results were available for 18 patients and were normal in 14 (78%). All 22 patients presented histological evidence of vasculitis with lymphocytic pattern being the most frequent. This was observed in 17 (77%) patients.
Twenty patients were treated with GC, and 14 received GC combined with CYC. Six patients also had a surgical resection of their lesions, which was the only treatment in two cases. Follow-up information was available for 16 patients. Two had relapsed and were being treated with higher dose of GC and CYC. The two patients who underwent resection only did not relapse. Two patients died and six patients had persistent disabilities.
